NYSE:IBIO
Ibio Inc Stock News
$4.06
+0.700 (+20.83%)
At Close: Mar 28, 2024
Why Is iBio's Stock Trading Higher Today?
10:42am, Friday, 07'th May 2021
iBio, Inc. (NYSE: IBIO) shares are trading higher after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate,
IBIO Stock: Over 30% Increase Intraday Explanation
09:32am, Friday, 07'th May 2021
The stock price of iBio, Inc. (NYSEA:IBIO) increased by over 30% during at the opening of the stock market today. This is why it happened.
iBio Stock Is Trading Higher After Announcing Next-Gen COVID-19 Vaccine Candidate
07:01am, Friday, 07'th May 2021
iBio Inc (NYSE: IBIO) has provided an update on its IBIO-201 program and reported its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevent
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
04:15pm, Thursday, 06'th May 2021
BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an updat
Why iBio Stock Soared Today
08:42pm, Wednesday, 05'th May 2021
A landmark legal settlement should bolster the biotech's growth prospects.
A Couple Key Levels To Watch In iBio's Stock
02:04pm, Wednesday, 05'th May 2021
iBio Inc. (NYSE:IBIO) shares gapped higher Wednesday morning after the company announced it successfully resolved its lawsuit with Fraunhofer USA. The resolution confirms iBio's ownership of certain i
IBIO Stock: The Big Lawsuit News That Has iBio Shares Rocketing Today
11:29am, Wednesday, 05'th May 2021
Ibio (IBIO) stock is on the rise Wednesday after announcing an end to its legal battle with Fraunhofer USA and settlement agreement. The post IBIO Stock: The Big Lawsuit News That Has iBio Shares Rock
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement
05:00pm, Tuesday, 04'th May 2021
BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it
7 Pharmaceutical Stocks That Could Get a Covid Hangover
05:01am, Thursday, 01'st Apr 2021
Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared f
Take Your Profits! 7 Covid Winners to Sell Now
11:36am, Tuesday, 23'rd Mar 2021
Because of the pandemic, many so-called Covid stocks enjoyed outsized gains but investors might want to consider trimming their exposure. The post Take Your Profits!
iBio Stock Is Not Likely To Move Higher Given Its Huge Dilution
05:13pm, Friday, 12'th Mar 2021
IBIO stock is not likely to move higher given its huge dilution. I think it is not worth more than 48 cents per share.
8 Biotech Penny Stocks for Investors to Watch
11:54am, Wednesday, 10'th Mar 2021
Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.
iBio to Participate in the 33rd Annual Roth Conference
04:30pm, Tuesday, 09'th Mar 2021
BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that
7 Penny Stocks In a Make-or-Break Year
01:07pm, Wednesday, 24'th Feb 2021
These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first
Hold iBio Shares as Q2 Highlights Strong Product Catalog
12:04pm, Monday, 22'nd Feb 2021
With iBio making key executive-level appointments and recording excellent fiscal stats, IBIO stock's value proposition is hard to ignore. The post Hold iBio Shares as Q2 Highlights Strong Product Cata